Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISOPROLOL | 10MG | TABLET | Resolved | 2017-10-17 | 2017-12-04 | 26154 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2018-08-21 | 2019-01-02 | 58580 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2020-09-09 | 2020-10-05 | 123914 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2024-04-12 | 2024-07-19 | 225023 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2018-01-17 | 2018-04-09 | 36268 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2018-05-22 | 2018-07-17 | 50041 |
| APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | SOLUTION | Resolved | 2024-05-03 | 2024-05-10 | 227028 |
| APO-BRIVARACETAM | 50MG | TABLET | Resolved | 2025-01-09 | 2025-02-14 | 247388 |
| APO-BRIVARACETAM | 75MG | TABLET | Resolved | 2025-01-23 | 2025-02-14 | 248486 |
| APO-BROMAZEPAM | 3MG | TABLET | Resolved | 2024-10-18 | 2024-10-25 | 240699 |
| APO-BROMAZEPAM | 1.5MG | TABLET | Resolved | 2018-05-15 | 2018-08-28 | 49484 |
| APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2023-12-01 | 2024-01-05 | 212389 |
| APO-BROMFENAC | 0.07% | SOLUTION | Resolved | 2024-01-19 | 2024-03-22 | 216678 |
| APO-BROMFENAC | 0.07% | SOLUTION | Actual shortage | 2025-07-10 | 2025-10-10 | 262439 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170109 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2023-02-09 | 2023-05-12 | 184072 |
| APO-BUSPIRONE | 10MG | TABLET | Actual shortage | 2024-01-26 | 2024-02-02 | 217484 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2017-05-24 | 2017-06-27 | 11056 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2017-10-23 | 2017-11-20 | 26564 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2021-01-29 | 2021-03-24 | 132706 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |